Form 4: STAAR Surgical CLO's RSU Vesting and Tax Withholding

Sentiment:

Insider Transaction Report


STAAR Surgical's Chief Legal Officer, Nathaniel Sisitsky, reported the vesting of 7,312 restricted stock units, with 2,616 shares withheld for tax obligations.

Summary

  • Nathaniel Sisitsky, Chief Legal Officer of STAAR SURGICAL CO (STAA), reported a transaction involving company common stock.
  • On December 11, 2025, 7,312 restricted stock units (RSUs) granted on December 11, 2023, vested.
  • Upon vesting, 2,616 shares were withheld by the company to satisfy tax obligations.
  • The price per share for the withheld shares was $24.68.
  • Following this transaction, Nathaniel Sisitsky beneficially owns 22,812 shares of common stock, which includes previously granted RSUs subject to future vesting.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While shares were withheld for taxes, the underlying event is the vesting of executive compensation, which is a positive for the individual and indicates retention. It's a routine transaction with no significant negative implications for the company's operations or outlook.

Positives

  • The vesting of 7,312 restricted stock units indicates the fulfillment of performance or time-based conditions, which is a positive event for the executive.
  • Nathaniel Sisitsky continues to hold a significant number of shares (22,812), demonstrating ongoing alignment with shareholder interests.

Negatives

  • 2,616 shares were withheld to cover tax liabilities, reducing the number of shares directly received by the executive from the vesting event.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation, common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends or competitive landscape for STAAR Surgical.

Stakeholder Impact

  • Shareholders: This is a routine executive compensation event and tax withholding, which is generally not expected to have a direct material impact on the company's share price or long-term value.
  • Employees: The vesting of RSUs is a standard component of executive compensation, aligning executive interests with company performance.

Key Dates

DateDescription
12/11/2023Date when restricted stock units (RSUs) were originally granted to the reporting person.
12/12/2023Date of the original Form 4 filing reporting the RSU grant.
12/11/2025Date when 7,312 restricted stock units vested and 2,616 shares were withheld for taxes.
12/12/2025Date of this Form 4 filing.

Keywords

STAAR Surgical, STAA, Nathaniel Sisitsky, Chief Legal Officer, Restricted Stock Units, RSU vesting, Insider transaction, Form 4, Equity compensation, Tax withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.